Keeping our Adult Patients Healthy and Active: The Role of Vaccines across the Lifespan

References

• Advisory Committee on Immunization Practices. Recommended adult immunization schedule—United States, 2010. Ann Intern Med. 2010;152(1):36–39
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Adult vaccination coverage, NHIS. http://www.cdc.gov/vaccines/stats-surv/nhis/2009-nhis.htm. Accessed November 17, 2010
   Google Scholar
• Anon. 10 Reasons to be vaccinated. National Foundation for Infectious Diseases: Bethesda, MD, 2009. http://www.adultvaccination.org/doc/10_reasons.pdf. Accessed September 2, 2010
   Google Scholar
• Cox NJ, Subbarao K. Influenza. Lancet. 1999;354(9186):1277–1282
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K,; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1–62
   PubMedGoogle Scholar
• Ciszewski A, Bilinska ZT, Brydak LB,. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29(11):1350–1358
   PubMed Web of Science ®Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;1:CD002733
   PubMed Web of Science ®Google Scholar
• Hak E, Buskens E, van Essen GA,. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165(3):274–280
   PubMedGoogle Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518–527
   PubMed Web of Science ®Google Scholar
• Nichol KL, Lind A, Margolis KL,. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333(14):889–893
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Influenza. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation; 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf. Accessed September 2, 2010
   Google Scholar
• Centers for Disease Control and Prevention. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 – April 10, 2010.http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm. Accessed September 2, 2010
   Google Scholar
• Viboud C, Miller M, Olson D, Osterholm M, Simonsen L. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr. 2010;2:RRN1153
   PubMedGoogle Scholar
• Nicholson KG. Clinical features of influenza. Semin Respir Infect. 1992;7(1):26–37
   PubMedGoogle Scholar
• Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986;76(7):761–765
   PubMedGoogle Scholar
• Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurrence of influenza in the community, 1966–1971. Am J Epidemiol. 1975;102(6):553–563
   PubMedGoogle Scholar
• McCullers JA, Facchini S, Chesney PJ, Webster RG. Influenza B virus encephalitis. Clin Infect Dis. 1999;28(4):898–900
   PubMedGoogle Scholar
• Morishima T, Togashi T, Yokota S,; Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35(5):512–517
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E,. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E,. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–1340
   PubMed Web of Science ®Google Scholar
• Kech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26(11):911–924
   PubMedGoogle Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML,. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096
   PubMed Web of Science ®Google Scholar
• IDSA News. ACIP targets pertussis vaccination gaps. http://news.idsociety.org/idsa/issues/2010-10-01/2.html. Accessed November 1, 2010
   Google Scholar
• California Department of Public Health. Pertussis report, 8/17/2010. http://www.cdph.ca.gov/programs/immunize/Documents/PertussisReport9-28-2010.pdf. Accessed October 4, 2010
   Google Scholar
• California Department of Public Health. CDPH broadens recommendations for vaccinating against pertussis: immunization key to controlling whooping cough. http://www.cdph.ca.gov/Pages/PH10-048.aspx. Accessed October 4, 2010
   Google Scholar
• Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations of the Immunization Practices Advisory committee (ACIP). MMWR Recomm Rep. 1991;40(RR-10):1–28
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Pertussis. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation; 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf. Accessed September 2, 2010
   Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24( 5 suppl):S58–S61
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Notice to readers: final 2009 reports of national notifiable infectious diseases. MMWR. 2010;59(32):1025–1027–1039
   Google Scholar
• Kretsinger K, Broder KR, Cortese MM,; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR-17):1–37
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Pertussis–United States, 1997-2000. MMWR Morb Mortal Wkly Rep. 2002;51(4):73–76
   PubMedGoogle Scholar
• Jackson AD. The Ohio Department of Health encourages back to school immunizations. August 2010. http://www.odh.ohio.gov/landing/jackson/columns.aspx. Accessed October 7, 2010
   Google Scholar
• Michigan Department of Community Health. Pertussis (whooping cough) in Michigan. http://www.michigan.gov/mdch/0,1607,7-132-2942_4911_4914-240419–,00.html. Accessed October 7, 2010
   Google Scholar
• New York Department of Health. State health commissioner urges vaccination for pertussis (whooping cough) as number of pertussis cases climbs above this period last year. http://www.nyhealth.gov/press/releases/2010/2010-09-24_pertussis.htm. Accessed October 7, 2010
   Google Scholar
• Pennsylvania Department of Health. 2010-PAHAN-0193-08-05-ADV—Pertussis. http://www.portal.health.state.pa.us/portal/server.pt/community/health_alert_network/14217. Accessed October 7, 2010
   Google Scholar
• South Carolina Department of Health and Environmental Control. Pertussis cases increasing, especially among infants. http://www.scdhec.gov/health/disease/han/docs/HAN-20100608-01.pdf. Accessed October 7, 2010
   Google Scholar
• Centers for Disease Control and Prevention. Pertussis. Number of reported cases, by age group—United States, 2007. http://www.cdc.gov/ncphi/disss/nndss/annsum/2007/07graphs.htm. Accessed September 2, 2010
   Google Scholar
• Cortese MM, Baughman AL, Brown K, Srivastava P. A “new age” in pertussis prevention new opportunities through adult vaccination. Am J Prev Med. 2007;32(3):177–185
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Pascual FB, Ehresmann KR,. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23(11):985–989
   PubMed Web of Science ®Google Scholar
• Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004;190(2):335–340
   PubMed Web of Science ®Google Scholar
• World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008;83(42):373–384
   PubMedGoogle Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008;1:CD000422
   PubMedGoogle Scholar
• Rehm SJ, Farley MM, File TM Jr,. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med. 2009;121(6):101–105
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Pneumococcal disease. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation; 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf. Accessed September 2, 2010
   Google Scholar
• File TM. Community-acquired pneumonia. Lancet. 2003;362(9400):1991–2001
   PubMed Web of Science ®Google Scholar
• Jackson ML, Neuzil KM, Thompson WW,. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–1650
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A,; Infectious Diseases Society of America, American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44( suppl 2):S27–S72
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2010. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, provisional–2009. http://www.cdc.gov/abcs/reports-findings/survreports/spneu09.pdf. Accessed September 15, 2010
   Google Scholar
• File TM, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122(2):130–141
   PubMed Web of Science ®Google Scholar
• Immunization Action Coalition. Ask the experts: Pneumococcal polysaccharide vaccine (PPSV). http://www.immunize.org/askexperts/expertsppv.asp. Accessed October 7, 2010
   Google Scholar
• Centers for Disease Control and Prevention. Human papillomavirus. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation; 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf. Accessed September 2, 2010
   Google Scholar
• Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):630–632
   PubMedGoogle Scholar
• Center for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59(20):626–629
   PubMedGoogle Scholar
• . Gardasil [package insert]. Whitehouse Station, NC: Merck and Co. Inc; 2009
   Google Scholar
• Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis. 2008;197(2):279–282
   PubMed Web of Science ®Google Scholar
• Dunne EF, Unger ER, Maya Sternberg S,. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–819
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer. 1995;76( 10 suppl):1888–1901
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Genital HPV infection – CDC fact sheet. November 2009. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed September 13, 2010
   Google Scholar
• Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194(8):1044–1057
   PubMed Web of Science ®Google Scholar
• Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, Desanjosé S,. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52(5):743–749
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Bauer HM, Hoover RN,. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958–964
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer facts and figures 2010. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010. Accessed September 13, 2010
   Google Scholar
• Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63–73
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24( suppl 3):11–25
   Web of Science ®Google Scholar
• Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics. 2005;23(11):1107–1122
   PubMedGoogle Scholar
• Oxman MN, Levin MJ, Johnson GR,; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–2284
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Kruszon-Moran D, Seward JF,. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003;70( suppl 1):S111–S118
   PubMedGoogle Scholar
• Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361–381
   PubMed Web of Science ®Google Scholar
• Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748–753
   PubMed Web of Science ®Google Scholar
• McDonald JR, Zeringue AL, Caplan L,. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48(10):1364–1371
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–1349
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and new hypothesis. Proc Royal Soc Med. 1965;58:9–20
   PubMedGoogle Scholar
• Gilden DH, Dueland AN, Cohrs R, Martin JR, Kleinschmidt-DeMasters BK, Mahalingam R. Preherpetic neuralgia. Neurology. 1991;41(8):1215–1218
   PubMedGoogle Scholar
• Mazur MH, Dolin R. Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978;65(5):738–744
   PubMed Web of Science ®Google Scholar
• Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis. 1988;158(1):238–241
   PubMed Web of Science ®Google Scholar
• Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Engl J Med. 1996;335(1):32–42
   PubMed Web of Science ®Google Scholar
• Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(12 suppl 8):S52–S53
   PubMedGoogle Scholar
• Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore).1982;61(5):310–316
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1–30
   PubMedGoogle Scholar
• Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186( suppl 1):S91–S98
   PubMed Web of Science ®Google Scholar